Corvus Pharmaceuticals, Inc. (CRVS) Form 10-Q Quarterly Reports
Corvus Pharmaceuticals, Inc. (CRVS) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CRVS
CIK: 1626971
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerDeepak Bhandarkar
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000443 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001104659-26-091975 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | FORM 8-K | 0001171843-26-005317 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-27 | — | SCHEDULE 13G/A Filing | 0002012383-26-002292 | View SEC Doc Filr Page |
| 8-K | 2026-07-22 | 2026-07-21 | 8-K | 0001104659-26-085790 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0001610717-26-000223 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0001610717-26-000222 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0001610717-26-000221 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0001610717-26-000220 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0001610717-26-000219 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-11 | FORM 8-K | 0001171843-26-004094 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-18 | 4 Filing | 0001610717-26-000160 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000919574-26-003462 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0000919574-26-003217 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | FORM 8-K | 0001171843-26-003397 | View SEC Doc Filr Page |
| S-8 | 2026-05-07 | — | FORM S-8 | 0001104659-26-057263 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001104659-26-057100 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | FORM 8-K | 0001171843-26-003154 | View SEC Doc Filr Page |
| 4 | 2026-04-27 | 2026-04-23 | 4 Filing | 0001610717-26-000149 | View SEC Doc Filr Page |
| 3 | 2026-04-27 | 2026-04-23 | 3 Filing | 0001610717-26-000148 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-04-27 | — | SCHEDULE 13G/A Filing | 0002012383-26-001739 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-24 | — | DEFA14A | 0001104659-26-048600 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-24 | 2026-06-11 | DEF 14A | 0001104659-26-048595 | View SEC Doc Filr Page |
| 8-K | 2026-04-23 | 2026-04-22 | 8-K | 0001104659-26-047735 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-03-26 | — | SCHEDULE 13G/A Filing | 0000102909-26-001004 | View SEC Doc Filr Page |